MASS Earnings Date: Nov 10, 2026 (Estimated) — 908 Devices Inc.
NASDAQ · Healthcare · Medical Devices
Updated
When is MASS's next earnings date?
908 Devices Inc. (MASS) is expected to report Q3 2026 earnings on Tuesday, November 10, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.16 on revenue of $18.3M.
How did MASS do in its last earnings report?
In its most recent report on Aug 11, 2026 (Q2 2026), 908 Devices Inc. posted EPS of -$0.32 versus the -$0.14 estimate, a miss of 128.6%. Revenue was $16.1M against a $15.4M estimate. The stock's 1-day post-earnings move was +13.8%.
How much does MASS stock move after earnings?
MASS beat EPS estimates in 2 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 20.4% (up or down) in the day after earnings.
About 908 Devices Inc.
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-11 | Q2 2026 | -0.14 | -0.32 | -128.57% | $16.1M | ❌ Miss | +13.75% | +15.80% | +10.11% |
| 2026-05-06 | Q1 2026 | -0.14 | -0.32 | -128.57% | $13.4M | ❌ Miss | +13.68% | +7.90% | +24.40% |
| 2026-03-03 | Q4 2025 | -0.06 | 0.11 | +283.33% | $17.4M | ✅ Beat | -4.39% | -3.71% | -7.41% |
| 2025-11-10 | Q3 2025 | -0.12 | -0.41 | -241.67% | $14.0M | ❌ Miss | -13.35% | -25.75% | -11.11% |
| 2025-08-05 | Q2 2025 | -0.15 | -0.36 | -140.00% | $13.0M | ❌ Miss | -2.76% | -1.38% | -15.34% |
| 2025-03-04 | Q4 2024 | -0.35 | -0.27 | +22.86% | $18.8M | ✅ Beat | +95.96% | +52.53% | +105.56% |
| 2024-11-12 | Q3 2024 | -0.28 | -0.30 | -7.14% | $16.8M | ❌ Miss | -19.34% | -34.81% | -37.57% |
| 2024-08-06 | Q2 2024 | -0.33 | -0.37 | -12.12% | $14.0M | ❌ Miss | +0.00% | -8.21% | -19.44% |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q2 FY26 · $16.1M total
| Segment | Share | Revenue | YoY | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 |
|---|---|---|---|---|---|---|---|
| Device Sales | 68.6% | $11.0M | +33.1% | $19.9M | — | $8.3M | $9.1M |
| Recurring | 30.8% | $4.9M | +4.5% | $12.7M | — | $4.7M | $4.8M |
| Contract | 0.6% | $104K | +420.0% | $276K | $63K | $20K | $54K |
By region
Q2 FY26 · $16.1M total
| Segment | Share | Revenue | YoY | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 |
|---|---|---|---|---|---|---|---|
| UNITED STATES | 73.7% | $11.8M | +8.4% | $21.1M | $7.0M | $10.9M | $11.2M |
| Europe, Middle East and Africa | 14.3% | $2.3M | +68.5% | $8.8M | $4.5M | $1.4M | $1.5M |
| Asia Pacific | 9.6% | $1.5M | +130.4% | $2.6M | $181K | $671K | $793K |
| Americas other | 2.4% | $383K | +463.2% | $370K | $130K | $68K | $443K |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.